跳至主要内容
临床试验/NCT05495451
NCT05495451已完成不适用

Feasibility and Impact of an Intensive Team-based Intervention on Type 2 Diabetes Reversal

Montreal Heart Institute1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2022年1月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36
试验地点
1
主要终点
Feasibility of an intensive multidisciplinary program based on lifestyle changes in patients diagnosed with type 2 diabetes.

研究概览

简要总结

To evaluate the feasibility of a 6-month multidisciplinary program to reverse type 2 diabetes using the Mediterranean diet, intermittent fasting and exercise.

详细描述

The morbidities associated with type 2 diabetes (Db2) are major, including cardiovascular and renal complications, but also cognitive impairment. Providing interventions targeting Db2 reversal has shown great potential to improve healthy aging.

A Db2 reversal clinic has been established at the Montreal Heart Institute's ÉPIC Center, with an approach based on the Mediterranean diet and exercise. First-year results showed a 0.6% decrease in Hb1Ac and an average weight loss at 3 months of 4.5 kg in diabetic patients. This improvement was maintained at 6 and 12 months. Although these results are encouraging, the literature in Db2 remission shows that a weight loss of 10 kg is the ideal goal.

Therefore, to offer the possibility of further metabolic improvement at 6 months, three interventions are proposed as additions to the current program: targeting ultra-processed food reduction, motivational coaching and intermittent fasting. The main objective of our pilot study is to determine the feasibility of this improved program in type 2 diabetic patients, aged 18 to 80 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

The randomisation will be effectuated with the participant number only for the Intermittent Fasting Intervention.

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Type 2 diabetes
  • •Ability to give written consent, to use a smartphone application or complete an adherence/compliance diary, and use a blood glucose and blood pressure machine at home.

排除标准

  • •All types of diabetes other than type 2
  • •Taking the following glucose-lowering agents: insulin, sulfonylureas
  • •BMI < 18,5 kg/m2
  • •Unintentional weight loss of more than 10 kg in the past year
  • •Moderate to severe retinopathy
  • •Pregnant or nursing woman
  • •Severe organ failure
  • •Pathologies predisposing to gastrointestinal bleeding, untreated
  • •Recent cholecystitis (3 months)
  • •Antibiotic use in the past 3 months, or untreated active infection
  • •Known impaired nutrient absorption
  • •Uninvestigated new anemia or Hb < 110 g/100 mL
  • •Currently following an intermittent or prolonged fasting protocol
  • •Currently following a specific diet (vegan, celiac/gluten free, ketogenic)
  • •Active diagnoses of psychiatric or neurological illness not controlled for at least 6 months
  • •Taking, stopping or adjusting a medication in the last 3 months resulting in an active weight change.

研究组 & 干预措施

Mediterranean diet and Personalized training

Experimental

36 participants will participate to the following lifestyle changes for 6 months:

Behavioral: Lifestyle changes Nutritional advice to progressively integrate a moderate-carbohydrate Mediterranean diet.

Personalized exercise prescription and training (3 times per week)

Personalized education and motivational interviewing

干预措施: Moderate-carbohydrate Mediterranean diet, Personalized exercice prescription and training, Intermittent fasting (Behavioral)

Intermittent Fasting Intervention

Active Comparator

Between 3 and 6 months, 24 participants (on a total of 36) will progressively integrate intermittent fasting 16:8 (5 times/week for 12 weeks) and 20:4 (2 times/week for 4 weeks)

干预措施: Moderate-carbohydrate Mediterranean diet, Personalized exercice prescription and training, Intermittent fasting (Behavioral)

结局指标

主要结局

Feasibility of an intensive multidisciplinary program based on lifestyle changes in patients diagnosed with type 2 diabetes.

时间窗: at 6 months after the start of the intervention

Total recruitment, recruitment rate, compliance and completion rate at 6 months after the start of the intervention

Feasibility of an intensive multidisciplinary program based on lifestyle changes in patients diagnosed with type 2 diabetes.

时间窗: at 3 months after the start of the intervention

Total recruitment, recruitment rate, compliance and completion rate at 3 months after the start of the intervention

次要结局

  • Proportion of diabetic participants in complete remission of diabetes.(at 3 and 6 months of the start of the intervention)
  • Evolution of the HOMA-IR between the start of the program, the middle of the intervention (3 months) and the end of the intervention (6 months).(at 3 and 6 months of the start of the intervention)

研究者

发起方
Montreal Heart Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Louis Bherer

Director of Centre EPIC research lab

Montreal Heart Institute

研究点 (1)

Loading locations...

相似试验